Advertisement

Adrenomedullin Receptor and Signal Transduction

  • Takanobu Yoshimoto
  • Yukio Hirata
Chapter
Part of the Basic Science for the Cardiologist book series (BASC, volume 19)

Keywords

Vasoactive Intestinal Peptide Calcitonin Gene Related Peptide Adrenal Medulla Complete Amino Acid Sequence Human Pheochromocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aiyar N, Rand K, Elshourbagy N A, Zeng Z, Adamou JE, Bergsma, DJ, and Li Y (1996) A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 271:11325–11329.CrossRefPubMedGoogle Scholar
  2. Albertin G, Carraro G, Pamigotto PP, Conconi MT, Ziolkowska A, Malendowicz LK, and Nussdorfer GG (2003) Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int J Mol Med 11:635–639.PubMedGoogle Scholar
  3. Aldecoa A, Gujer R, Fischer JA, and Bom W (2000) Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells. FEBS Lett 471:156–160.CrossRefPubMedGoogle Scholar
  4. Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, Caron MG, and Lefkowitz RJ. (1985) Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 260:7094–7101.PubMedGoogle Scholar
  5. Bom W, Muff R, and Fischer JA. (2002) Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP). Microsc Res Tech 57:14–22.CrossRefPubMedGoogle Scholar
  6. Chini EN, Choi E, Grande JP, Bumett JC, and Dousa TP. (1995) Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 215:868–873.CrossRefPubMedGoogle Scholar
  7. Christopoulos G, Peny KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, and Sexton PM. (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56:235–242.PubMedGoogle Scholar
  8. Coppock HA, Owji AA, Bloom SR, and Smith DM. (1996) A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors. Biochem J 318:241–245.PubMedGoogle Scholar
  9. Eguchi S, Hirata Y, Iwasaki H, Sato K, Watanabe TX, Inui T, Nakajima K, Sakakibara S, and Marunmo E. (1994a) Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135:2454–2458.CrossRefPubMedGoogle Scholar
  10. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, Nakajima K, Sakakibara S, and Marumo E. (1994b) Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 340:226–230.CrossRefPubMedGoogle Scholar
  11. Elshourbagy NA, Adamou JE, Swift AM, Disa J, Mao J, Ganguly S, Bergsma DJ, and Aiyar N. (1998) Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor. Endocrinology 139:1678–1683.CrossRefPubMedGoogle Scholar
  12. Entzeroth M, Doods HN, Wieland HA, and Wienen W. (1995) Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci 56:PL19–25.CrossRefPubMedGoogle Scholar
  13. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, and Dickerson IM. (2000) CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 275:31438–31443.CrossRefPubMedGoogle Scholar
  14. Flahaut M, Rossier BC, and Firsov D. (2002) Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J Biol Chem 277:14731–14737.PubMedGoogle Scholar
  15. Fluhmann B, Muff R, Hunziker W, Fischer JA, and Bom W. (1995) A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 206:341–347.CrossRefPubMedGoogle Scholar
  16. Fukai N, Shichiri M, Ozawa N, Matsushita M, and Hirata Y. (2003) Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin. Endocrinology 144:447–453.CrossRefPubMedGoogle Scholar
  17. Gether U. (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90–113.CrossRefPubMedGoogle Scholar
  18. Hall JM, Siney L, Lippton H, Hyman A, Kang-Chang J, and Brain SD. (1995) Interaction of human adrenomedullin 13–52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. Br J Pharmacol 114:592–597.PubMedGoogle Scholar
  19. Han ZQ, Coppock HA, Smith DM, Van Noorden S, Makgoba MW, Nicholl CG, and Legon S. (1997) The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J Mol Endocrinol 18:267–272.CrossRefPubMedGoogle Scholar
  20. Hausdorff WP, Bouvier M, O’Dowd BF, Irons GP, Caron MG, and Lefkowitz RJ. (1989) Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem 264:12657–12665.PubMedGoogle Scholar
  21. Hilairet S, Foord SM, Marshall FH, and Bouvier M. (2001) Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J Biol Chem 276:29575–29581.CrossRefPubMedGoogle Scholar
  22. Hinson JP, Kapas S, and Smith DM. (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138–167.CrossRefPubMedGoogle Scholar
  23. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, and Maummo F. (1996) Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 81:1449–1453.CrossRefPubMedGoogle Scholar
  24. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, and Takeda T. (1995) Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 77:660–664.PubMedGoogle Scholar
  25. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, and Eto T. (1993) Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 241:271–273.CrossRefPubMedGoogle Scholar
  26. Iwasaki H, Eguchi S, Shichiri M, Marumo F, and Hirata Y. (1998a) Adrenomedullinm as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 139:3432–3441.CrossRefPubMedGoogle Scholar
  27. Iwasaki H, Eguchi S, Shichiri M, Manuio F, and Hirata Y. (1998b) Down-regulation of adenylate cyclase coupled to adrenomedullin receptor in vascular smooth muscle cells. Eur J Pharmacol 352:131–134.CrossRefPubMedGoogle Scholar
  28. Iwasaki H, Shichiri M, Marumo F, and Hirata Y. (2001) Adrenomedullin stimulates proline-rich tyrosine kinase 2 in vascular smooth muscle cells. Endocrinology 142:564–572.CrossRefPubMedGoogle Scholar
  29. Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, Minami M, Hanehira T, Takeda T, and Yoshikawa J. (1996) Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 14:209–213.PubMedGoogle Scholar
  30. Kapas S, Brown DW, Farthing PM, and Hagi-Pavli E. (1997) Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett 418:287–290.CrossRefPubMedGoogle Scholar
  31. Kato H, Shichiri M, Manuno F, and Hirata Y (1997) Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 138:2615–2620.CrossRefPubMedGoogle Scholar
  32. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, So JN, and Park SK. (2003) Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 17:1937–1939.PubMedGoogle Scholar
  33. Kitamura K, Kangawa K, and Eto T. (2002) Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 57:3–13.CrossRefPubMedGoogle Scholar
  34. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, and Eto T. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–560.CrossRefPubMedGoogle Scholar
  35. Kohno M, Yokokawa K, Kano H, Yasunari K, Minami M, Hanehira T, and Yoshikawa J. (1997) Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells. Hypertension 29:1309–1313.PubMedGoogle Scholar
  36. Kohno M, Yasunari K, Minami M, Kano H, Maeda K, Mandel AK, Inoki K, Haneda M, and Yoshikawa J. (1999) Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin. J Am Soc Nephrol 10:2495–2502.PubMedGoogle Scholar
  37. Leuthauser K, Gujer R, Aldecoa A, McKinney RA, Muff R, Fischer JA, and Bom W (2000) Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition. Biochem J 351:347–351.CrossRefPubMedGoogle Scholar
  38. Lin HY, Hams TL, Flannery MS, Aruffo A, Kaji EH, Gom A, Kolakowski LF Jr., Lodish HF, and Goldring SR. (1991) Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254:1022–1024.PubMedGoogle Scholar
  39. Luebke AE, Dahll GP, Roos BA, and Dickerson IM. (1996) Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc Natl Acad Sci U S A 93:3455–3460.CrossRefPubMedGoogle Scholar
  40. Martinez A, Elsasser TH, Muro-Cacho C, Moody TW, Miller MJ, Macri CJ, and Cuttitta F. (1997) Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology 138:5597–5604.CrossRefPubMedGoogle Scholar
  41. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339.CrossRefPubMedGoogle Scholar
  42. Miller MI, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, and Cuttitta F. (1996) Adrenomedullin expression in human tumor celi lines. Its potential role as an autocrine growth factor. J Biol Chem 271:23345–23351.CrossRefPubMedGoogle Scholar
  43. Muff R, Buhlmann N, Fischer JA, and Bom W. (1999) An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or-3. Endocrinology 140: 2924–2927.CrossRefPubMedGoogle Scholar
  44. Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K, Sata M, Kangawa K, Matsuo H, Goto A, Kitamura T, and Hirata Y. (2001) Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 89:63–70.PubMedGoogle Scholar
  45. Njuki F, Nicholl CG, Howard A, Mak JC, Bames PJ, Girgis SI, and Legon S. (1993) A new calcitonin-receptor-like sequence in rat pulmonaiy blood vessels. Clin Sci (Lond) 85:385–388.Google Scholar
  46. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, and Wada A. (1993) Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 196:245–251.CrossRefPubMedGoogle Scholar
  47. Nussdorfer GG, Rossi GP, and Mazzocchi G. (1997) Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 18:1079–1089.CrossRefPubMedGoogle Scholar
  48. Oehler MK, Norbury C, Hague S, Rees MC, and Bicknell R. (2001) Adrenomedullin inhibits hypoxic celi death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 20:2937–2945.CrossRefPubMedGoogle Scholar
  49. Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yunati C, and Kangawa K. (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injuty through the phosphatidylinositol 3-kinase/Akt-dependentpathway. Circulation 109:242–248.CrossRefPubMedGoogle Scholar
  50. Owji AA, Gardiner JV, Upton PD, Mahmoodi M, Ghatei MA, Bloom SR, and Smith DM. (1996) Characterisation and molecular identification of adrenomedullin binding sites in the rat spinal cord: a comparison with calcitonin gene-related peptide receptors. J Neurochem 67:2172–2179.PubMedGoogle Scholar
  51. Owji AA, Smith DM, Coppock HA, Morgan DG, Bhogal R, Ghatei MA, and Bloom SR. (1995) An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 136:2127–2134.CrossRefPubMedGoogle Scholar
  52. Parkes DG, and May CN. (1997) Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 120:1179–1185.PubMedGoogle Scholar
  53. Pelengaris S, Khan M, and Evan G. (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2:764–776.CrossRefPubMedGoogle Scholar
  54. Poyner DR, Sexton P M, Marshall I, Smith DM, Quirion R, Bom W, Muff R, Fischer JA, and Foord SM. (2002) Intemational Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233–246.CrossRefPubMedGoogle Scholar
  55. Prado MA, Evans-Bain B, Oliver KR, and Dickerson IM. (2001) The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 22:1773–1781.CrossRefPubMedGoogle Scholar
  56. Rebuffat P, Fomens ML, Aragona F, Ziolkowska A, Malendowicz LK, and Nussdorfer GG. (2002) Adrenomedullin and its receptors are expressed in the zona glomerulosa of human adrenal gland: evidence that ADM enhances proliferation and decreases apoptosis in cultured ZG cells. Int J Mol Med 9:119–124.PubMedGoogle Scholar
  57. Segawa K, Minami K, Sata T, Kuroiwa A, and Shigematsu A. (1996) Inhibitory effect of adrenomedullin on rat mesangial cell mitogenesis. Nephron 74:577–579.PubMedGoogle Scholar
  58. Shichiri M, Fukai N, Ozawa N, Iwasaki H, and Hirata Y (2003) Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells. Regul Pept 112:167–173.CrossRefPubMedGoogle Scholar
  59. Shichiri M, and Hirata Y (2003) Regulation of cell growth and apoptosis by adrenomedullin. Hypertens Res 26:S9–14.PubMedGoogle Scholar
  60. Shichiri M, Kato H, Doi M, Marumo F, and Hirata Y (1999) Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol 13:1353–1363.CrossRefPubMedGoogle Scholar
  61. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, Eto T, Kangawa K, and Matsuo H. (1995) Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 270:4412–4417.CrossRefPubMedGoogle Scholar
  62. Shimosawa T, Shibasaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, and Fujita T. (2002) Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 105:106–111.CrossRefPubMedGoogle Scholar
  63. Shindo T, Kurihara Y, Nishimatsu H, Monyama N, Kakoki M, Wang Y, Imai Y, Ebihara A, Kuwaki T, Ju KH, Minamino N, Kangawa K, Ishikawa T, Fukuda M, Akimoto Y, Kawakami H, Imai T, Monta H, Yazaki Y, Nagai R, Hirata Y, and Kurihara H. (2001) Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104:1964–1971.PubMedGoogle Scholar
  64. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, and Matsuo H. (1995) Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 207:25–32.CrossRefPubMedGoogle Scholar
  65. Takahashi K, Satoh F, Hara E, Murakami O, Kumabe T, Tominaga T, Kayama T, Yoshimoto T, and Shibahara S. (1997a) Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells. J Neurochem 68:726–731.PubMedGoogle Scholar
  66. Takahashi K, Satoh F, Hara E, Sone M, Murakami O, Kayama T, Yoshimoto T, and Shibahara S. (1997b) Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides 18:1117–1124.CrossRefPubMedGoogle Scholar
  67. Togawa M, Haneda M, Araki S, Sugimoto T, Isono M, Hidaka H, Yasuda H, Kashiwagi A, and Kikkawa R (1997) Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells. Eur J Pharmacol 336:291–294.CrossRefPubMedGoogle Scholar
  68. Wang HY, Hadcock JR, and Malbon CC. (1990) Beta-adrenergic receptor regulation. New insights on biochemical and molecular mechanisms. Receptor 1:13–32.PubMedGoogle Scholar
  69. Withers DJ., Coppock HA., Seufferlein T, Smith DM, Bloom SR, and Rozengurt E. (1996) Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett 378:83–87.CrossRefPubMedGoogle Scholar
  70. Yin H, Chao L, and Chao J. (2004) Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension 43:109–116.CrossRefPubMedGoogle Scholar
  71. Ym X, Grove L, and Prochownik EV. (1998) Lack of transcriptional repression by maxhomodimers. Oncogene 16:2629–2637.CrossRefPubMedGoogle Scholar
  72. Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, and Hirata Y. (2004) Anti-oxidant effect of adrenomedullin on angiotensin II-induced ROS generation in vascular smooth muscle cells. Endocrinology 145:3331–3337.CrossRefPubMedGoogle Scholar
  73. Zimmermann U, Fischer JA, and Muff R. (1995) Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides 16:421–424.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Takanobu Yoshimoto
    • 1
  • Yukio Hirata
    • 1
  1. 1.Deparanent of Clinical and Molecular EndocinologyTokyo Medical and Deatal Univrsity Graduate SchoolTokyoJapan

Personalised recommendations